Tsumura & Co.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 4 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/02/05 | ¥90.93 | ¥142.95 | +57.2% |
| 2025/11/09 | ¥90.93 | ¥108.49 | +19.3% |
| 2025/08/04 | ¥90.93 | ¥58.16 | -36.0% |
| 2025/05/11 | ¥124.55 | ¥77.27 | -38.0% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.
|
1.2M | +43.05% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
972.0K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
641.7K | +0.98% | |
|
Victory Portfolios-Victory Trivalent International Small-Cap Fund
|
541.2K | -0.07% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
454.5K | +4.92% | |
|
Bridge Builder Trust-Bridge Builder International Equity Fund
|
445.2K | -2.26% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥79 | -41.9% |
| 2025 | ¥136 | +15.3% |
| 2024 | ¥118 | +76.1% |
| 2023 | ¥67 | +4.7% |
| 2022 | ¥64 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥129,546M | ¥140,043M | ¥150,845M | ¥181,093M |
| Gross Profit | ¥66,465M | ¥68,281M | ¥68,816M | ¥90,583M |
| Operating Income | ¥22,377M | ¥20,916M | ¥20,017M | ¥40,125M |
| Pretax Income | ¥25,736M | ¥23,274M | ¥24,066M | ¥46,077M |
| Net Income | ¥18,836M | ¥16,482M | ¥16,707M | ¥32,428M |
| EPS | ¥246.21 | ¥215.63 | ¥219.83 | ¥427.15 |
| Operating Margin | 17.27% | 14.94% | 13.27% | 22.16% |
| Balance Sheet | ||||
| Total Assets | ¥350,981M | ¥396,813M | ¥428,254M | ¥464,380M |
| Total Equity | ¥239,769M | ¥252,045M | ¥270,801M | ¥300,528M |
| Total Liabilities | ¥111,212M | ¥144,768M | ¥157,453M | ¥163,852M |
| Cash | ¥67,552M | ¥94,752M | ¥78,075M | ¥73,227M |
| Interest-bearing Debt | ¥49,690M | ¥79,690M | ¥79,690M | ¥70,336M |
| Equity Ratio | 68.31% | 63.52% | 63.23% | 64.72% |
| D/E Ratio | 0.21 | 0.32 | 0.29 | 0.23 |
| Cash Flow | ||||
| Operating CF | ¥21,314M | ¥16,452M | ¥5,608M | ¥33,823M |
| Investing CF | -¥9,111M | -¥15,493M | -¥19,351M | -¥24,974M |
| Financing CF | -¥8,181M | ¥24,423M | -¥4,417M | -¥19,871M |
| Free CF | ¥10,727M | ¥1,744M | -¥14,449M | ¥4,029M |
| Efficiency | ||||
| ROE | 7.86% | 6.54% | 6.17% | 10.79% |
| ROA | 5.37% | 4.15% | 3.90% | 6.98% |
Latest IR Information
-
Financial Summary for FY2027 Q1
Consolidated results for the first quarter of FY2027 were announced. Revenue 43,094 million yen, Operating income 7,719 million yen, Net income attributable to owners of the parent 4,367 million yen. Details on domestic and international segment revenue composition, cost items,...
Read more -
Q1 FY2027 Earnings Report for the Period Ended March 2027 (Japanese GAAP)
Consolidated results for the first quarter of FY2027. Revenue is expected to increase year over year; disclosure of trends in domestic and international segment revenue. Key indicators by segment revenue, cost of sales, SG&A, operating income, ordinary income, and quarterly...
Read more -
[Tsumura] Announces Executive Change | June 2026
Tsumura Co., Ltd. announced a change in the position of the President and Representative Director, Kei Sugii, scheduled for June 26, 2026, aiming to strengthen management control and accelerate decision-making.
Read more -
【Tsumura】2026 Fiscal Year Quarterly Earnings Supplementary Materials | Sales of ¥181 billion (up 6.4% YoY)
According to Tsumura's FY2026 quarterly earnings supplementary materials, sales reached ¥181 billion (up 6.4% YoY), with operating and net income also trending upward. Segments show strong performance domestically and in China.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥4,400
Rating Score: 2.75 (Based on 4 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.
